Dec 17, 2019
Notice of Change in Representative Directors
| Name of listed company: | Chugai Pharmaceutical Co., Ltd. |
| Code number: | 4519 (1st Section of Tokyo Stock Exchange) |
| Head office: | 1-1, Nihonbashi-Muromachi 2-Chome, Chuo-ku, Tokyo |
| President & CEO: | Tatsuro Kosaka |
| Inquiries to: | Masahiko Uchida, |
| General Manager, Corporate Communications Dept. | |
| Tel:+81-(0)3-3273-0881 |
Chugai Pharmaceutical Co., Ltd. (the “Company”) hereby announces a change in Representative Directors with the resolution of the Board of Directors Meeting held on December 17, 2019 as described below. The change will be formalized after the Annual General Meeting of Shareholders and the Board of Directors Meeting to be held in late March, 2020.
1. Reason for change
To further enhance management efficiency and expedite decision making under a system where the CEO is responsible for making decisions on corporate-level strategic issues and other material issues, and the COO is responsible for overall operational issues.
2. Details of change
(Newly Appointed)
Name: Tatsuro Kosaka
New Title: Representative Director, Chairman and Chief Executive Officer (CEO)
Name: Osamu Okuda
New Title: Representative Director, President and Chief Operating Officer (COO)
(To Retire)
Name: Osamu Nagayama
Former Title: Representative Director, Chairman
*Osamu Nagayama is expected to be appointed as Honorary Chairman
3. Career summary of the newly appointed representative directors
| Name / Date of Birth | Career Summary | No. of Shares Held (in thousands) |
||||||||||||||||||||||||
| Tatsuro Kosaka (January 18, 1953) |
|
52.3 shares | ||||||||||||||||||||||||
| Osamu Okuda (April 5, 1963) |
|
9.8 shares |
4. Effective Date
Late March, 2020
